Open AccessPrimary pancreatic lymphoma: A rare cause of pancreatic mass
Author(s) -
Birol Baysal,
Yusuf Kayar,
Ali Tüzün İnce,
Sema Arıcı,
İhsan Türkmen,
Hakan Şentürk
Publication year - 2015
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2015.3412
Subject(s) - medicine , pancreatic mass , rituximab , vincristine , pancreatic cancer , differential diagnosis , pancreatic tumor , fine needle aspiration , adenocarcinoma , cyclophosphamide , endoscopic ultrasound , gastroenterology , lymphoma , pancreas , biopsy , radiology , cancer , chemotherapy , pathology
Primary pancreatic lymphoma (PPL) is a rare entity, most likely to be clinically misdiagnosed as pancreatic cancer. The cure rate of PPL is higher compared with that of pancreatic adenocarcinoma. This is the case report of a 57-year-old male patient who was hospitalized with complaints of abdominal pain, weight loss and jaundice. The radiological evaluation revealed a pancreatic head mass and, following endoscopic ultrasound-guided fine-needle aspiration biopsy, the tumor was diagnosed as diffuse large B-cell lymphoma. The final diagnosis was PPL, and the patient went into remission after receiving three cycles of treatment with rituximab, doxorubicin, cyclophosphamide, vincristine and prednisolone (R-CHOP regimen). Therefore, PPL should be considered in the differential diagnosis of pancreatic masses and its management differs from that of other types of pancreatic tumor.